Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up


All communities will be placed in read-only mode (you will be able to see and search for posts but not start or reply to discussions) as we conduct maintenance. We will make another announcement when posting is re-opened. Thank you for your continued support and patience, and if you have any further questions, please email

Yours in health,
WebMD Community Management

Includes Expert Content
worn1 posted:
Anyone using DM-1992? If so how is it working for you? Dr Stacy have you prescribed this drug and what are your thoughts? It is suppose to stay in the somach for 8 hours. does this mean f ewer pills and better management of movement.
There are none so blind as those that will not see
Mark A Stacy, MD responded:
Hi, worn1
DM-1922 is a drug being studied by a California company, Depomed. There are no publications listed in the company website, and the registry provides no data, other than the study title. There appears to have been 2 studies completed. A phase 1 trial in Russia showed promise, and lead to a Phase 2 safety trial in the US with 37 participants. The results are encouraging, but we will have to see if fewer daily doses can be achieved.
worn1 replied to Mark A Stacy, MD's response:
Thank you Dr Stacy
There are none so blind as those that will not see

Helpful Tips

What would you like to know?Expert
Over the last month the PD Exchange has addressed topics concerning diagnosis, medications, managing doctor's office visits, sleep ... More
Was this Helpful?
22 of 32 found this helpful

Related Drug Reviews

  • Drug Name User Reviews

Report Problems With Your Medications to the FDA

FDAYou are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

For more information, visit the Duke Health Neurological Disorders Center